Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Breast Cancer × balixafortide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Advanced Breast Cancer 1

Interventions

sacituzumab govitecan 1 eribulin 1 balixafortide 1 Taxes 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04826016 2023-03-20

POLTER

MedSIR

Phase 1/2 Withdrawn

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡